苹果Apple Watch或将实现无创测血糖，血糖仪龙头股价跳水跌10%，智能穿戴概念股拉升

金融界2023-02-23

一则关于无创测血糖的消息，让A股市场的智能穿戴、苹果概念走高，血糖监测相关个股却纷纷下挫。据悉，苹果公司正在进行一个可以追溯到乔布斯时代的重大项目——使用Apple Watch实现无创和持续的血糖监测。这项被称为E5的秘密研究的目标是在不需要刺破皮肤取血的情况下，成功测量人体内的葡萄糖含量。据知情人士透露，苹果公司最近在这一领域取得了一些重大进展，并认为它最终可以将葡萄糖监测技术推向市场。如果此次...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

zhaojb
2023-02-23
zhaojb
自己开发不出来就说别人开发的不行

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2313484882?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-02-23 13:26","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2313484882","market":"us","top_or_hot":-1,"title":"苹果Apple Watch或将实现无创测血糖，血糖仪龙头股价跳水跌10%，智能穿戴概念股拉升","media":"金融界","content":"<div>\n<p>一则关于无创测血糖的消息，让A股市场的智能穿戴、苹果概念走高，血糖监测相关个股却纷纷下挫。据悉，苹果公司正在进行一个可以追溯到乔布斯时代的重大项目——使用Apple Watch实现无创和持续的血糖监测。这项被称为E5的秘密研究的目标是在不需要刺破皮肤取血的情况下，成功测量人体内的葡萄糖含量。据知情人士透露，苹果公司最近在这一领域取得了一些重大进展，并认为它最终可以将葡萄糖监测技术推向市场。如果此次...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302231329188260f3f5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>苹果Apple Watch或将实现无创测血糖，血糖仪龙头股价跳水跌10%，智能穿戴概念股拉升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n苹果Apple Watch或将实现无创测血糖，血糖仪龙头股价跳水跌10%，智能穿戴概念股拉升\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-23 13:26 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302231329188260f3f5&s=b><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>一则关于无创测血糖的消息，让A股市场的智能穿戴、苹果概念走高，血糖监测相关个股却纷纷下挫。据悉，苹果公司正在进行一个可以追溯到乔布斯时代的重大项目——使用Apple Watch实现无创和持续的血糖监测。这项被称为E5的秘密研究的目标是在不需要刺破皮肤取血的情况下，成功测量人体内的葡萄糖含量。据知情人士透露，苹果公司最近在这一领域取得了一些重大进展，并认为它最终可以将葡萄糖监测技术推向市场。如果此次...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302231329188260f3f5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0149725797.USD","symbol_name":"汇丰美国股市经济规模基金","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302231329188260f3f5&s=b","article_id":"2313484882","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302231329188260f3f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2313484882","pubTimestamp":1677129992,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"一则关于无创测血糖的消息，让A股市场的智能穿戴、苹果概念走高，血糖监测相关个股却纷纷下挫。据悉，苹果公司正在进行一个可以追溯到乔布斯时代的重大项目——使用Apple Watch实现无创和持续的血糖监测。据知情人士透露，苹果公司最近在这一领域取得了一些重大进展，并认为它最终可以将葡萄糖监测技术推向市场。因此，预计无创技术短期内无法在血糖监测医疗需求层面取代采血方式。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0149725797.USD":"汇丰美国股市经济规模基金","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU0127658192.USD":"EASTSPRING INVESTMENTS GLOBAL TECHNOLOGY \"A\" (USD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","BK4554":"元宇宙及AR概念","BK4515":"5G概念","BK4532":"文艺复兴科技持仓","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","LU0238689110.USD":"贝莱德环球动力股票基金","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","BK4575":"芯片概念","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","LU0072462426.USD":"贝莱德全球配置 A2","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4573":"虚拟现实","BK4566":"资本集团","BK4571":"数字音乐概念","BK4170":"电脑硬件、储存设备及电脑周边","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","IE00BJJMRY28.SGD":"Janus Henderson Balanced A Inc SGD","LU0308772762.SGD":"Blackrock Global Allocation A2 SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4581":"高盛持仓","BK4559":"巴菲特持仓","BK4501":"段永平概念","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","AAPL":"苹果","LU0109392836.USD":"富兰克林科技股A","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4576":"AR","BK4574":"无人驾驶","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","BK4505":"高瓴资本持仓","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","BK4512":"苹果概念","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC"},"translate_title":"Apple Watch will realize non-invasive blood glucose measurement, the leading stock price of blood glucose meter will plunge by 10%, and smart wear concept stocks will rise","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AAPL":0.9},"content_text":"一则关于无创测血糖的消息，让A股市场的智能穿戴、苹果概念走高，血糖监测相关个股却纷纷下挫。据悉，苹果公司正在进行一个可以追溯到乔布斯时代的重大项目——使用Apple Watch实现无创和持续的血糖监测。这项被称为E5的秘密研究的目标是在不需要刺破皮肤取血的情况下，成功测量人体内的葡萄糖含量。据知情人士透露，苹果公司最近在这一领域取得了一些重大进展，并认为它最终可以将葡萄糖监测技术推向市场。如果此次技术突破得到完善，对糖尿病患者来说将是一个福音，并有助于巩固苹果在医疗保健领域的霸主地位。受此消息影响，A股智能穿戴、苹果概念股纷纷异动，奋达科技（002681）迅速涨停，乐心医疗（300562）、立讯精密（002475）等异动拉升。不过，以“国产血糖仪一哥”三诺生物（300298）为首的血糖监测概念股则大幅走弱，其中三诺生物午后一度跌超10%，信立泰（002294）、鱼跃医疗（002223）等纷纷走弱。国内方面，据报道，国内已有多项无创血糖检测相关实用新型专利获得授权，申请(专利权)人包括医疗器械公司、医院、高校等。不过据证券时报最新报道称，国内血糖监测龙头企业相关人士向记者表示，目前主流血糖监测使用电化学方法，通过采血方式精准监测人体血液中葡萄糖含量，满足医疗层级血糖检测需求；苹果的无创方式则使用物理方法，检测精度欠缺，仅能用于普通人群消费层级的血糖自测，无法满足血糖患者的精准监测需求。因此，预计无创技术短期内无法在血糖监测医疗需求层面取代采血方式。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":624194727,"gmtCreate":1677142081870,"gmtModify":1677142083487,"author":{"id":"3493540034590216","authorId":"3493540034590216","name":"zhaojb","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3493540034590216","authorIdStr":"3493540034590216"},"htmlText":"自己开发不出来就说别人开发的不行","listText":"自己开发不出来就说别人开发的不行","text":"自己开发不出来就说别人开发的不行","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/624194727","repostId":2313484882,"repostType":2,"repost":{"id":"2313484882","kind":"news","pubTimestamp":1677129992,"share":"https://www.laohu8.com/m/news/2313484882?lang=&edition=full","pubTime":"2023-02-23 13:26","market":"us","language":"zh","title":"苹果Apple Watch或将实现无创测血糖，血糖仪龙头股价跳水跌10%，智能穿戴概念股拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2313484882","media":"金融界","summary":"一则关于无创测血糖的消息，让A股市场的智能穿戴、苹果概念走高，血糖监测相关个股却纷纷下挫。据悉，苹果公司正在进行一个可以追溯到乔布斯时代的重大项目——使用Apple Watch实现无创和持续的血糖监测。据知情人士透露，苹果公司最近在这一领域取得了一些重大进展，并认为它最终可以将葡萄糖监测技术推向市场。因此，预计无创技术短期内无法在血糖监测医疗需求层面取代采血方式。","content":"<html><body><article><p>一则关于无创测血糖的消息，让A股市场的<a href=\"https://laohu8.com/S/5RE.SI\">智能</a>穿戴、<a href=\"https://laohu8.com/S/AAPL\">苹果</a>概念走高，血糖监测相关个股却纷纷下挫。</p><p>据悉，苹果公司正在进行一个可以追溯到乔布斯时代的重大项目——使用Apple Watch实现无创和持续的血糖监测。</p><p>这项被称为E5的秘密研究的目标是在不需要刺破皮肤取血的情况下，成功测量人体内的葡萄糖含量。据知情人士透露，苹果公司最近在这一领域取得了一些重大进展，并认为它最终可以将葡萄糖监测技术推向市场。如果此次技术突破得到完善，对糖尿病患者来说将是一个福音，并有助于巩固苹果在医疗保健领域的霸主地位。</p><p>受此消息影响，A股智能穿戴、苹果概念股纷纷异动，<a href=\"https://laohu8.com/S/002681\">奋达科技</a>（002681）迅速涨停，<a href=\"https://laohu8.com/S/300562\">乐心医疗</a>（300562）、<a href=\"https://laohu8.com/S/002475\">立讯精密</a>（002475）等异动<span>拉升</span>。</p><p>不过，以“国产血糖仪一哥”<a href=\"https://laohu8.com/S/300298\">三诺生物</a>（300298）为首的血糖监测概念股则大幅走弱，其中三诺生物午后一度跌超10%，信立泰（002294）、<a href=\"https://laohu8.com/S/002223\">鱼跃医疗</a>（002223）等纷纷走弱。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20230223132917303v24786tklkkuhs6\"/><p>国内方面，据报道，国内已有多项无创血糖检测相关实用新型专利获得授权，申请(专利权)人包括医疗器械公司、医院、高校等。</p><p>不过据证券时报最新报道称，国内血糖监测龙头企业相关人士向记者表示，目前主流血糖监测使用电化学方法，通过采血方式精准监测人体血液中葡萄糖含量，满足医疗层级血糖检测需求；苹果的无创方式则使用物理方法，检测精度欠缺，仅能用于普通人群消费层级的血糖自测，无法满足血糖患者的精准监测需求。因此，预计无创技术短期内无法在血糖监测医疗需求层面取代采血方式。</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>苹果Apple Watch或将实现无创测血糖，血糖仪龙头股价跳水跌10%，智能穿戴概念股拉升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n苹果Apple Watch或将实现无创测血糖，血糖仪龙头股价跳水跌10%，智能穿戴概念股拉升\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-23 13:26 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302231329188260f3f5&s=b><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>一则关于无创测血糖的消息，让A股市场的智能穿戴、苹果概念走高，血糖监测相关个股却纷纷下挫。据悉，苹果公司正在进行一个可以追溯到乔布斯时代的重大项目——使用Apple Watch实现无创和持续的血糖监测。这项被称为E5的秘密研究的目标是在不需要刺破皮肤取血的情况下，成功测量人体内的葡萄糖含量。据知情人士透露，苹果公司最近在这一领域取得了一些重大进展，并认为它最终可以将葡萄糖监测技术推向市场。如果此次...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302231329188260f3f5&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU0234572021.USD":"高盛美国核心股票组合Acc","BK4559":"巴菲特持仓","LU0109392836.USD":"富兰克林科技股A","BK4501":"段永平概念","AAPL":"苹果","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4574":"无人驾驶","LU0097036916.USD":"贝莱德美国增长A2 USD","BK4573":"虚拟现实","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","BK4505":"高瓴资本持仓","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","BK4581":"高盛持仓","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","BK4512":"苹果概念","LU0149725797.USD":"汇丰美国股市经济规模基金","LU0127658192.USD":"EASTSPRING INVESTMENTS GLOBAL TECHNOLOGY \"A\" (USD) ACC","BK4170":"电脑硬件、储存设备及电脑周边","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","LU0238689110.USD":"贝莱德环球动力股票基金","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU0072462426.USD":"贝莱德全球配置 A2","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","BK4571":"数字音乐概念","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","BK4585":"ETF&股票定投概念","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4534":"瑞士信贷持仓","BK4576":"AR","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","BK4575":"芯片概念","IE00BJJMRY28.SGD":"Janus Henderson Balanced A Inc SGD","LU0308772762.SGD":"Blackrock Global Allocation A2 SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302231329188260f3f5&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2313484882","content_text":"一则关于无创测血糖的消息，让A股市场的智能穿戴、苹果概念走高，血糖监测相关个股却纷纷下挫。据悉，苹果公司正在进行一个可以追溯到乔布斯时代的重大项目——使用Apple Watch实现无创和持续的血糖监测。这项被称为E5的秘密研究的目标是在不需要刺破皮肤取血的情况下，成功测量人体内的葡萄糖含量。据知情人士透露，苹果公司最近在这一领域取得了一些重大进展，并认为它最终可以将葡萄糖监测技术推向市场。如果此次技术突破得到完善，对糖尿病患者来说将是一个福音，并有助于巩固苹果在医疗保健领域的霸主地位。受此消息影响，A股智能穿戴、苹果概念股纷纷异动，奋达科技（002681）迅速涨停，乐心医疗（300562）、立讯精密（002475）等异动拉升。不过，以“国产血糖仪一哥”三诺生物（300298）为首的血糖监测概念股则大幅走弱，其中三诺生物午后一度跌超10%，信立泰（002294）、鱼跃医疗（002223）等纷纷走弱。国内方面，据报道，国内已有多项无创血糖检测相关实用新型专利获得授权，申请(专利权)人包括医疗器械公司、医院、高校等。不过据证券时报最新报道称，国内血糖监测龙头企业相关人士向记者表示，目前主流血糖监测使用电化学方法，通过采血方式精准监测人体血液中葡萄糖含量，满足医疗层级血糖检测需求；苹果的无创方式则使用物理方法，检测精度欠缺，仅能用于普通人群消费层级的血糖自测，无法满足血糖患者的精准监测需求。因此，预计无创技术短期内无法在血糖监测医疗需求层面取代采血方式。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2313484882"}